Effect of latanoprost on outflow facility in the mouse

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 7, 2004, Pages 2240-2245

  Crowston, Jonathan G ^a   Aihara, Makoto ^a,b   Lindsey, James D ^a   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; LATANOPROST; RHODAMINE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR FLOW; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; DILUTION; DOSE RESPONSE; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; INTRAOCULAR PRESSURE; MICE; PROSTAGLANDINS F, SYNTHETIC; SCLERA; TRABECULAR MESHWORK; UVEA;

EID: 3142581893     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0990     Document Type: Article

References (31)

1. 2α on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res. 1990;51:87-91.
2. 2α-1-isopropylester in the cynomolgus monkey. Exp Eye Res. 1989;48:707-716.
3. Toris CB, Camras CB, Yablonski ME, Brubaker RF. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol. 1997;41(suppl 2): S69-S75.
4. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993;100:1297-1304.
5. Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47(suppl 1):S53-S64.
6. 2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol. 1993;111:1351-1358.
7. Toris CB, Zhan GL, Zhao J, Camras CB, Yablonski ME. Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol. 2001;131:722-728.
8. Brubaker RF. Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol. 2001;45(suppl 4):S347-S351.
9. Brubaker RF, Schoff EO, Nau CB, Carpenter SP, Chen K, Vandenburgh AM. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol. 2001;131:19-24.
10. 2α-isopropylester eye drops: effects in normal human eyes. Br J Ophthalmol. 1989;73:419-426.
11. Sakurai M, Araie M, Oshika T, et al. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol. 1991;35:156-165.
12. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997;38:2772-2780.
13. Lindsey JD, Kashiwagi K, Boyle D, Kashiwagi F, Firestein GS, Weinreb RN. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res. 1996;15:869-875.
14. Aihara M, Lindsey JD, Weinreb RN. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:146-150.
15. Savinova OV, Sugiyama F, Martin JE, et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001;2:12.
16. Aihara M, Lindsey JD, Weinreb RN. Twenty-four-hour pattern of mouse intraocular pressure. Exp Eye Res. 2003;77:681-686.
17. Aihara M, Lindsey JD, Weinreb RN. Episcleral venous pressure of the mouse eye and effect of body position. Curr Eye Res. 2003;27:355-362.
18. Aihara M, Lindsey JD, Weinreb RN. Aqueous humor dynamics in mice. Invest Ophthalmol Vis Sci. 2003;44:5168-5173.
19. Brubaker RF, Kupfer C. Determination of pseudofacility in the eye of the rhesus monkey. Arch Ophthalmol. 1966;75:693-697.
20. Bill A. Uveoscleral drainage of aqueous humor: physiology and pharmacology. Prog Clin Biol Res. 1989;312:417-427.
21. Avila MY, Mitchell CH, Stone RA, Civan MM. Noninvasive assessment of aqueous humor turnover in the mouse eye. Invest Ophthalmol Vis Sci. 2003;44:722-727.
22. John SW, Hagaman JR, MacTaggart TE, Peng L, Smithes O. Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci. 1997;38:249-253.
23. Grierson I, Lee WR. The fine structure of the trabecular meshwork at graded levels of intraocular pressure. (1) Pressure effects within the near-physiological range (8-30 mmHg). Exp Eye Res. 1975;20:505-521.
24. Grierson I, Lee WR. Pressure-induced changes in the ultrastructure of the endothelium lining Schlemm's canal. Am J Ophthalmol. 1975;80:863-884.
25. Grierson I, Lee WR. The fine structure of the trabecular meshwork at graded levels of intraocular pressure. (2) Pressures outside the physiological range (0 and 50 mm Hg). Exp Eye Res. 1975;20:523-530.
26. Grozdanic SD, Betts DM, Sakaguchi DS, Allbaugh RA, Kwon YH, Kardon RH. Laser-induced mouse model of chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2003;44:4337-4346.
27. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle: a study on cultured cells and tissue sections. Exp Eye Res. 1998;67:179-191.
28. 2α-isopropyl ester treatment. Arch Ophthalmol. 2001;119:1165-1170.
29. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 1997;38:2214-2223.
30. 2α treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol. 1999;117:794-801.
31. Weinreb RN, Lindsey JD. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:716-722.